Growth Stock Portfolio: 12 Stock Picks by Carl C. Icahn
Carl Icahn is a legendary and often feared figure in American finance, widely considered the pioneer of modern activist investing.
Bausch & Lomb Corp (BLCO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Icahn Capital LP Carl Icahn | 3,500,000 | $55,650,000 | 0.65% | |
| 2. | Oaktree Capital Management Howard Marks | 3,382,739 | $53,785,550 | 0.82% | |
| 3. | D E Shaw D. E. Shaw | 3,151,167 | $50,103,555 | +11% | 0.03% |
| 4. | GoldenTree Asset Management Steven Tananbaum | 2,660,508 | $42,210,264 | 2.5% | |
| 5. | Silver Point Capital Edward A. Mule | 2,245,000 | $35,695,500 | -13% | 2.74% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.13 | 4,000 | $68,520.00 | 403,130 | 2026-03-06 | Filing | |
| $17.68 | 4,500 | $79,555.50 | 64,891 | 2026-03-03 | Filing | |
| $17.90 | 4,300 | $76,970.00 | 9,555 | 2026-03-02 | Filing | |
| $18.31 | 4,364 | $79,883.02 | 66,450 | 2026-02-27 | Filing | |
| $17.81 | 15,000 | $267,150.00 | 20,255 | 2026-02-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.06 | 4,550,357 | $77,606,338.64 | 310,449,643 | 2022-06-01 | Filing | |
| $17.06 | 35,000,000 | $596,925,000.00 | 315,000,000 | 2022-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,528,441 | $56,102,212 | 0.02% | |
| 2. | 1,256,181 | $19,973,278 | 0.05% | |
| 3. | 845,914 | $13,450,033 | 0% | |
| 4. | 825,000 | $13,117,500 | 3.15% | |
| 5. | 453,179 | $7,205,547 | 0% |
News See All
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2026 Earnings Call Transcript
Operator: Good morning, and welcome to Bausch + Lomb's First Quarter 2026 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
10 High Growth Canadian Stocks to Buy Now
For more than a decade, U.S. equities have been the default destination for global investors.
Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth
Bausch + Lomb Corporation (NYSE:BLCO) is one of the best Canadian stocks to buy under $20.
10 Best Canadian Stocks to Buy Under $20
On February 21, Brianne Gardner, senior wealth manager at Velocity Investment Partners, Raymond James, appeared on BNN Bloomberg to share her outlook on the shifting landscape of the Canadian and US markets...
Bausch + Lomb Corporation (NYSE:BLCO) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Bausch + Lomb's Fourth Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded.
9 Best Up and Coming Canadian Stocks to Buy
On November 19, IG Wealth Management released its 2026 Market Outlook for Canada.
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2025 Earnings Call Transcript
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2025 Earnings Call Transcript October 29, 2025Bausch + Lomb Corporation misses on earnings expectations.
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Bausch + Lomb's Second Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Barclays lowered its price target on Bausch & Lomb (NYSE: BLCO) from $19 to $16 on June 6, maintaining an Equalweight rating.
Hedge Fund Resource Center